☰

Ann M. Saunders, PhD

Affiliations: 
GlaxoSmithKline, Collegeville, PA, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=50
Website:
http://www.linkedin.com/pub/ann-saunders/6/313/604
Google:
"Ann Saunders"
Bio:

http://www.biomedexperts.com/Profile.bme/1247766/Ann_M_Saunders

http://www.bloomberg.com/apps/news?pid=newsarchive&refer=us&sid=abzQ9z1ak0dM

Mean distance: 106866
 
Cross-listing: Alzheimer's Tree

Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Saunders AM, Burns DK, Gottschalk WK. (2021) Reassessment of Pioglitazone for Alzheimer's Disease. Frontiers in Neuroscience. 15: 666958
Pytte J, Flynn LL, Anderton RS, et al. (2020) Disease-modifying effects of an structural variant in a predominantly ALS cohort. Neurology. Genetics. 6: e470
Theunissen F, Flynn LL, Anderton RS, et al. (2020) Structural Variants May Be a Source of Missing Heritability in sALS. Frontiers in Neuroscience. 14: 47
Burns DK, Chiang C, Welsh-Bohmer KA, et al. (2019) The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial. Alzheimer's & Dementia (New York, N. Y.). 5: 661-670
Alexander R, Burns DK, Welsh-Bohmer KA, et al. (2019) DT-02-02: TOMMORROW: RESULTS FROM A PHASE 3 TRIAL TO DELAY THE ONSET OF MCI DUE TO AD AND QUALIFY A GENETIC BIOMARKER ALGORITHM Alzheimer's & Dementia. 15: P1488-P1489
Zietlow K, Charalambous L, Ng I, et al. (2018) Corrigendum to "The Biological Foundation of the Genetic Association of TOMM40 with Late-onset Alzheimer's disease" [Biochim. Biophys. Acta 1863/11 (2017) 2973-2986]. Biochimica Et Biophysica Acta
Lutz MW, Chiba-Falek O, Burns DK, et al. (2018) F2-03-01: Untangling The Genetic Complexity Of Late Onset Alzheimer'S Disease Alzheimers & Dementia. 14
Chiang C, Alexander R, Welsh-Bohmer KA, et al. (2018) P1-050: Adjudicating Mild Cognitive Impairment Due To Alzheimer'S Disease As A Novel Endpoint Event In The Tommorrow Study: A Delay-Of-Onset Phase 3 Clinical Trial Alzheimers & Dementia. 14
Nishimura A, Nonomura H, Tanaka S, et al. (2017) Characterization of APOE and TOMM40 allele frequencies in the Japanese population. Alzheimer's & Dementia (New York, N. Y.). 3: 524-530
Zeitlow K, Charlambous L, Ng I, et al. (2017) The Biological Foundation of the Genetic Association of TOMM40 with Late-onset Alzheimer's disease. Biochimica Et Biophysica Acta
See more...